Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H de Jager

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Annals of the Rheumatic Diseases|September 10, 2020
Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trialElise van Mulligen, Angelique E Weel, Tjallingius Martijn Kuijper, et al.
Rheumatology (Oxford, England)|September 2, 2016
Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trialPascal H P de Jong, Johanna M Hazes, Leander R Buisman, et al.
Annals of the Rheumatic Diseases|April 5, 2007
Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)Yvonne P M Goekoop-Ruiterman, Jeska K de Vries-Bouwstra, Cornelia F Allaart, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2023
Inhalable Textile Microplastic Fibers Impair Airway Epithelial DifferentiationShanshan Song, Fransien van Dijk, Gwenda F Vasse, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Annals of the Rheumatic Diseases|September 10, 2020
Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trialElise van Mulligen, Angelique E Weel, Tjallingius Martijn Kuijper, et al.
Rheumatology (Oxford, England)|September 2, 2016
Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trialPascal H P de Jong, Johanna M Hazes, Leander R Buisman, et al.
Annals of the Rheumatic Diseases|April 5, 2007
Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)Yvonne P M Goekoop-Ruiterman, Jeska K de Vries-Bouwstra, Cornelia F Allaart, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2023
Inhalable Textile Microplastic Fibers Impair Airway Epithelial DifferentiationShanshan Song, Fransien van Dijk, Gwenda F Vasse, et al.
Pageof 5